Simon Vyse
Impact in
-
- Lung Cancer Treatments and Mutations
- Sarcoma Diagnosis and Treatment
-
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Sarcoma Diagnosis and Treatment 1
-
- Systemic Lupus Erythematosus Research 4
- Co-authors
- Paul H. Huang (13 shared papers)Aik Choon Tan (3 shared papers)Timothy James Vyse (4 shared papers)Myles J Lewis (4 shared papers)Adrian Matthew Shields (3 shared papers)Patrick Gordon (3 shared papers)Andrew D. Jenks (3 shared papers)Henning Walczak (2 shared papers)
- Journals
- Cell Reports (2 papers)The Lancet (1 paper)The Journal of Pathology (1 paper)Current Opinion in Oncology (1 paper)Oncotarget (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Simon Vyse
17 papers receiving 1.3k citations
Simon Vyse's Hit Papers
Peers
Comparison fields: 5 of 76
- Pulmonary and Respiratory Medicine 618
- Cancer Research 96
- Oncology 139
- Rheumatology 84
- Molecular Biology 221
Countries citing papers authored by Simon Vyse
This map shows the geographic impact of Simon Vyse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Vyse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Vyse more than expected).
Fields of papers citing papers by Simon Vyse
This network shows the impact of papers produced by Simon Vyse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Vyse. The network helps show where Simon Vyse may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Vyse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer Hit paper breakdown → | 2019 | 457 |
| 2 | Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer Hit paper breakdown → | 2019 | 300 |
| 3 | 2018 | 93 | |
| 4 | 2015 | 87 | |
| 5 | 2016 | 46 | |
| 6 | 2017 | 37 | |
| 7 | 2016 | 36 | |
| 8 | 2016 | 32 | |
| 9 | 2016 | 31 | |
| 10 | 2017 | 27 | |
| 11 | 2021 | 25 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 23 | |
| 14 | 2016 | 21 | |
| 15 | 2015 | 16 | |
| 16 | 2017 | 13 | |
| 17 | 2017 | 12 |
About Simon Vyse
Simon Vyse is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Cancer Research, Spectroscopy and Immunology and Allergy, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Systemic Lupus Erythematosus Research (4 papers), Advanced Proteomics Techniques and Applications (2 papers), Genetic and Kidney Cyst Diseases (1 paper), Cancer Genomics and Diagnostics (1 paper), Sarcoma Diagnosis and Treatment (1 paper), NF-κB Signaling Pathways (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (618 citations), Cancer Research (96 citations), Oncology (139 citations), Rheumatology (84 citations) and Molecular Biology (221 citations). Simon Vyse has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul H. Huang, Aik Choon Tan, Timothy James Vyse, Myles J Lewis, Adrian Matthew Shields, Patrick Gordon, Andrew D. Jenks, Henning Walczak, Tim D. Spector and Sebastian Boeltz. Their work appears in journals such as Cell Reports, The Lancet, The Journal of Pathology, Current Opinion in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.